U.S. flag

An official website of the United States government

NM_007289.4(MME):c.1445A>C (p.Tyr482Ser) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jul 31, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001767178.6

Allele description [Variation Report for NM_007289.4(MME):c.1445A>C (p.Tyr482Ser)]

NM_007289.4(MME):c.1445A>C (p.Tyr482Ser)

Gene:
MME:membrane metalloendopeptidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q25.2
Genomic location:
Preferred name:
NM_007289.4(MME):c.1445A>C (p.Tyr482Ser)
HGVS:
  • NC_000003.12:g.155147172A>C
  • NG_051105.1:g.128049A>C
  • NM_000902.5:c.1445A>C
  • NM_001354642.2:c.1445A>C
  • NM_001354643.1:c.1445A>C
  • NM_007287.4:c.1445A>C
  • NM_007288.3:c.1445A>C
  • NM_007289.4:c.1445A>CMANE SELECT
  • NP_000893.2:p.Tyr482Ser
  • NP_001341571.1:p.Tyr482Ser
  • NP_001341572.1:p.Tyr482Ser
  • NP_009218.2:p.Tyr482Ser
  • NP_009219.2:p.Tyr482Ser
  • NP_009220.2:p.Tyr482Ser
  • NC_000003.11:g.154864961A>C
  • NM_007289.2:c.1445A>C
Protein change:
Y482S
Links:
dbSNP: rs201936237
NCBI 1000 Genomes Browser:
rs201936237
Molecular consequence:
  • NM_000902.5:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354642.2:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354643.1:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007287.4:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007288.3:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007289.4:c.1445A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001991058GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Jun 11, 2019)
germlineclinical testing

Citation Link,

SCV002188907Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 31, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV001991058.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002188907.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with MME-related conditions. This variant is present in population databases (rs201936237, ExAC 0.002%). This sequence change replaces tyrosine with serine at codon 482 of the MME protein (p.Tyr482Ser). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and serine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024